190 related articles for article (PubMed ID: 26017316)
21. Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis.
Wang HH; Abern MR; Cost NG; Chu DI; Ross SS; Wiener JS; Routh JC
J Urol; 2014 Oct; 192(4):1196-202. PubMed ID: 24735935
[TBL] [Abstract][Full Text] [Related]
22. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
23. Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: a population-based evaluation.
Bianchi M; Becker A; Abdollah F; Trinh QD; Hansen J; Tian Z; Shariat SF; Perrotte P; Karakiewicz PI; Sun M
Int J Urol; 2013 Nov; 20(11):1064-71. PubMed ID: 23418921
[TBL] [Abstract][Full Text] [Related]
24. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.
Lane BR; Abouassaly R; Gao T; Weight CJ; Hernandez AV; Larson BT; Kaouk JH; Gill IS; Campbell SC
Cancer; 2010 Jul; 116(13):3119-26. PubMed ID: 20564627
[TBL] [Abstract][Full Text] [Related]
25. Health status and use of partial nephrectomy in older adults with early-stage kidney cancer.
Tan HJ; Daskivich TJ; Shirk JD; Filson CP; Litwin MS; Hu JC
Urol Oncol; 2017 Apr; 35(4):153.e7-153.e14. PubMed ID: 27955941
[TBL] [Abstract][Full Text] [Related]
26. Overall survival advantage with partial nephrectomy: a bias of observational data?
Shuch B; Hanley J; Lai J; Vourganti S; Kim SP; Setodji CM; Dick AW; Chow WH; Saigal C;
Cancer; 2013 Aug; 119(16):2981-9. PubMed ID: 23674264
[TBL] [Abstract][Full Text] [Related]
27. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
28. Sociodemographic disparities in the treatment of small renal masses.
Becker A; Roghmann F; Trinh QD; Hansen J; Tian Z; Shariat SF; Noldus J; Perrotte P; Graefen M; Karakiewicz PI; Sun M
BJU Int; 2013 Jun; 111(8):E274-82. PubMed ID: 23714645
[TBL] [Abstract][Full Text] [Related]
29. Treatment for T1a Renal Cancer Substratified by Size: "Less is More".
Moskowitz D; Chang J; Ziogas A; Anton-Culver H; Clayman RV
J Urol; 2016 Oct; 196(4):1000-7. PubMed ID: 27113965
[TBL] [Abstract][Full Text] [Related]
30. Life Expectancy and Variation in Treatment for Early Stage Kidney Cancer.
Daskivich TJ; Tan HJ; Litwin MS; Hu JC
J Urol; 2016 Sep; 196(3):672-7. PubMed ID: 27012644
[TBL] [Abstract][Full Text] [Related]
31. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
32. Influence of renal biopsy results on the management of small kidney cancers in older patients: Results from a population-based cohort.
Bjurlin MA; Elkin EB; Atoria CL; Russo P; Taneja SS; Huang WC
Urol Oncol; 2017 Oct; 35(10):604.e1-604.e9. PubMed ID: 28716561
[TBL] [Abstract][Full Text] [Related]
33. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.
Scosyrev E; Messing EM; Sylvester R; Campbell S; Van Poppel H
Eur Urol; 2014 Feb; 65(2):372-7. PubMed ID: 23850254
[TBL] [Abstract][Full Text] [Related]
34. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Cancer Specific Outcomes following Minimally Invasive and Open Surgical Resection of Early Stage Kidney Cancer from a National Cancer Registry.
Auffenberg GB; Curry M; Gennarelli R; Blum KA; Elkin E; Russo P
J Urol; 2020 Jun; 203(6):1094-1100. PubMed ID: 31913076
[TBL] [Abstract][Full Text] [Related]
36. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
37. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
38. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
39. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
[TBL] [Abstract][Full Text] [Related]
40. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
